Literature DB >> 25481488

Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.

Haruhiko Nakamura1, Hisashi Saji2, Takuo Shinmyo2, Rie Tagaya2, Noriaki Kurimoto2, Hirotaka Koizumi3, Masayuki Takagi3.   

Abstract

OBJECTIVES: Correlations between maximum standardized uptake value (SUVmax) in fluorodeoxyglucose positron emission tomography (FDG-PET) and IASLC/ATS/ERS histopathologic subtypes of lung adenocarcinoma remain unclear. Therefore, the aim of this study was to retrospectively clarify associations between SUVmax and adenocarcinoma subtypes with postoperative outcomes.
MATERIALS AND METHODS: Associations of SUVmax measured in preoperative FDG-PET/CT and histologic subtypes of lung adenocarcinoma resected in our hospital were analyzed retrospectively. Overall and disease-free survival rates after surgery were calculated by the Kaplan-Meier method, and survival differences between patient groups were tested by the log-rank test. Multivariate analysis for survival was performed using the Cox regression model.
RESULTS: A total of 255 patients (130 men and 125 women; mean age, 69 years; range, 22-88 years) were included in the study. Clinical stages included IA in 151 patients, IB in 79, IIA in 9, IIB in 10, and IIIA in 6. SUVmax was closely associated with histologic subtype in resected specimens (p<0.0001). Values were highest in micropapillary predominant invasive adenocarcinoma (MPA) followed by solid predominant (SPA), invasive mucinous (IMA), acinar predominant (APA), papillary predominant (PPA), lepidic predominant (LPA), minimally invasive adenocarcinoma (MIA), and adenocarcinoma in situ (AIS). When the subtypes were classified into three subgroups [group A, AIS+MIA+LPA (low risk); group B, APA+PPA+IMA (intermediate risk); and group C, SPA+MPP (high risk)] by expected postoperative prognoses, there were significant differences in SUVmax among the subgroups corresponding to recurrence risk (p=0.0001).
CONCLUSION: Preoperative SUVmax was closely associated with both adenocarcinoma subtype and aggregated subgroups, reflecting malignant grade of the tumor and prognosis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Histology; Lung cancer; Subtype; Surgery; Survival

Mesh:

Substances:

Year:  2014        PMID: 25481488     DOI: 10.1016/j.lungcan.2014.11.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  27 in total

1.  Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients.

Authors:  Duilio Divisi; Mirko Barone; Luca Bertolaccini; Gaetano Rocco; Piergiorgio Solli; Roberto Crisci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates.

Authors:  Shanyuan Zhang; Shaolei Li; Yuquan Pei; Miao Huang; Fangliang Lu; Qingfeng Zheng; Nan Li; Yue Yang
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.

Authors:  Jonathan E Leeman; Andreas Rimner; Joseph Montecalvo; Meier Hsu; Zhigang Zhang; Donata von Reibnitz; Kelly Panchoo; Ellen Yorke; Prasad S Adusumilli; William Travis; Abraham J Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-29       Impact factor: 7.038

4.  Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.

Authors:  Xiaoyan Sun; Tianxiang Chen; Chun Xie; Liu Liu; Bei Lei; Lihua Wang; Maomei Ruan; Hui Yan; Qi Zhang; Cheng Chang; Wenhui Xie
Journal:  BMJ Open       Date:  2022-05-17       Impact factor: 3.006

5.  Expression of fibroblast activation protein in lung cancer and its correlation with tumor glucose metabolism and histopathology.

Authors:  Xiaohui Chen; Xinran Liu; Lijuan Wang; Wenlan Zhou; Yin Zhang; Ying Tian; Jianer Tan; Ye Dong; Lilan Fu; Hubing Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-07       Impact factor: 10.057

6.  FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

Authors:  Marina Suárez-Piñera; José Belda-Sanchis; Alvaro Taus; Albert Sánchez-Font; Antoni Mestre-Fusco; Marcel Jiménez; Lara Pijuan
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.

Authors:  Cheng Chang; Xiaoyan Sun; Wenlu Zhao; Rui Wang; Xiaohua Qian; Bei Lei; Lihua Wang; Liu Liu; Maomei Ruan; Wenhui Xie; Junkang Shen
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

8.  Investigating the association between ground-glass nodules glucose metabolism and the invasive growth pattern of early lung adenocarcinoma.

Authors:  Xiaoliang Shao; Xiaonan Shao; Rong Niu; Zhenxing Jiang; Mei Xu; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-08

9.  Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.

Authors:  Hyun Woo Jeon; Young-Du Kim; Sung Bo Sim; Mi Hyoung Moon
Journal:  Thorac Cancer       Date:  2021-05-25       Impact factor: 3.500

Review 10.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.